Expression of the inflammasome component NLRP3 and the pro-inflammatory cytokine IL-1β is increased in samples from CRMO patients when compared to LHC patients or healthy controls. The gene discussed is NLRP3; the disease is chronic recurrent multifocal osteomyelitis.